Dr. James Miskin

Chief Quality and Technical Officer

James Miskin

Dr. Miskin joined Oxford Biomedica in 2000. He has more than 23 years of experience in cell and gene therapy, 19 of which have been in the GxP (good practice) environment. In his current role as a member of the corporate executive team (CET), he has global responsibility for Oxford Biomedica’s Quality systems, CMC Regulatory, and Technical Excellence across the group. He is also a named inventor on several patents in the field. He holds a Bachelor of Science degree and a PhD in Molecular Biology from the University of Leeds and subsequently conducted post-doctoral research at The Pirbright Institute for a number of years. He is Director of the OXB-led collaborative training partnership (CTP), which is a 7 year doctoral training programme funded by BBSRC, and is a partnership between OXB, the University of Oxford, and UCL. He is a member of the UK BioIndustry Association Manufacturing Advisory Committee and is the Advanced Therapies workstream lead for The Medicines Manufacturing Industry Partnership (MMIP).